अगला

स्वत: प्ले

Long-term trial supports CD19-targeted CAR T cells for relapsed/refractory CLL

2 विचारों • 07/14/23
शेयर करना
एम्बेड
administrator
administrator
ग्राहकों
0

In this episode, Mark Geyer and colleagues demonstrate that second-generation CD19-targeted CAR T cell therapy following conditioning chemotherapy is tolerated in patients with relapsed/refractory CLL and can result in complete remission in a subset of patients…

और दिखाओ
0 टिप्पणियाँ sort इसके अनुसार क्रमबद्ध करें
फेसबुक टिप्पणियाँ

अगला

स्वत: प्ले